Wanbury informs about closure of trading window

30 Dec 2022 Evaluate

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, Wanbury has informed that the Trading Window for dealing in securities of the Company shall remain closed for the Designated Persons Directors, identified Employees, KMPs, Promoter and Promoter Group of the Company and its subsidiaries including Immediate Relatives of the Designated Persons of the Company and its subsidiaries and for the Connected Persons commencing from 1st January, 2023 till 48 hours after the declaration of Un-audited Financial Results (UFR) of the Company for the quarter and nine months ended 31st December, 2022. The date of the Board Meeting of the Company for declaration of Un-audited Financial Results for the quarter and nine months ended 31st December, 2022 will be intimated in due course of time.

The above information is a part of company’s filings submitted to BSE.

Wanbury Share Price

151.05 -6.10 (-3.88%)
29-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1521.95
Dr. Reddys Lab 6279.95
Cipla 1407.55
Zydus Lifesciences 963.50
Lupin 1640.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.